Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

FBIOFBIO
8 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in FORTRESS BIOTECH INC

Yes. Citadel Advisors holds 77,065 shares of FBIO (Fortress Biotech), worth $235,819, as of its Q2 2026 13F filing. It reduced the position by 103,224 shares (-57.3%) from Q1 2026. Citadel Advisors has held FBIO since Q1 2026, across 2 quarterly 13F filings.

Current Value

$235,819

Current Shares

77,065

Total Value Change

+$219,925

Total Shares Change

+67,770

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
77,065
-57.3%
$235,8190.0%$3.06
0
2026-Q1
New
180,289
-
$503,0060.0%$2.79
33
2025-Q3
Exited
0
-100.0%
$00.0%$3.70
0
2025-Q2
Increased
123,892
+860.9%
$230,4390.0%$1.86
25
2025-Q1
Decreased
12,893
-92.7%
$20,1130.0%$1.56
0
2024-Q4
Increased
175,761
+394.2%
$355,9160.0%$2.03
38
2024-Q3
Increased
35,563
+282.6%
$51,3890.0%$1.45
23
2024-Q2
New
9,295
-
$15,8940.0%$1.71
28

Other major holders of FBIO: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, MACKENZIE FINANCIAL CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used